RhumbLine Advisers’s Eledon Pharmaceuticals ELDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $152K | Buy |
+56,050
| New | +$152K | ﹤0.01% | 3375 |
|
|
2017
Q2 | – | Sell |
-31,937
| Closed | -$27K | – | 2932 |
|
|
2017
Q1 | $27K | Buy |
+31,937
| New | +$27K | ﹤0.01% | 2838 |
|
|
2016
Q2 | – | Sell |
-11,418
| Closed | -$64K | – | 2992 |
|
|
2016
Q1 | $64K | Buy |
11,418
+620
| +6% | +$3.48K | ﹤0.01% | 2949 |
|
|
2015
Q4 | $94K | Buy |
10,798
+705
| +7% | +$6.14K | ﹤0.01% | 2962 |
|
|
2015
Q3 | $104K | Buy |
+10,093
| New | +$104K | ﹤0.01% | 2940 |
|